Status:
UNKNOWN
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Technion, Israel Institute of Technology
Conditions:
Group 1: Trauma Operation for Otherwise Healthy Patients
Group 2: Primary Tumors of Mesenchymal Origin
Eligibility:
All Genders
18+ years
Brief Summary
Stage 1: Bone marrow will be collected from otherwise healthy patients undergoing orthopedic surgery - arthroplasty for the treatment of degenerative joint disease or traumatised patients. The bone m...
Detailed Description
Stage 1: Bone marrow will be collected from otherwise healthy patients undergoing orthopedic surgery - arthroplasty for the treatment of degenerative joint disease or traumatised patients. The bone m...
Eligibility Criteria
Inclusion
- Group 1:
- Healthy patients undergoing orthopedic surgery - arthroplasty for the treatment of degenerative joint disease or traumatised patients.
Exclusion
- Any malignancy in the past or active infection.
- Group 2:
- Inclusion Criteria:
- patients with malignancies of musculoskeletal origin.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02256241
Start Date
October 1 2014
End Date
July 1 2019
Last Update
February 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam MC
Haifa, Israel